Predictors of premature clopidogrel discontinuation within 30 days of successful coronary artery stenting
- Resource Type
- article
- Authors
- Çayan Cakir; Haci Ates; Baris Kiliçaslan; Cem Nazli; Oktay Ergene
- Source
- International Journal of the Cardiovascular Academy, Vol 4, Iss 1, Pp 1-5 (2018)
- Subject
- Clopidogrel
mortality
stent
Diseases of the circulatory (Cardiovascular) system
RC666-701
- Language
- English
- ISSN
- 2618-6012
2405-8181
Objective: We aimed to determine the prevalence, predictors, and mortality rate of premature clopidogrel discontinuation within 30 days of successful coronary stenting. Methods: All consecutive patients who underwent successful coronary stent implantation at our hospital between December 2006 and December 2007 were prospectively included in this study. Patients were interviewed by telephone 30 days after stent implantation. Premature clopidogrel discontinuation was defined as follows: patients who did not continue clopidogrel after discharge were defined as “never used” and patients who received clopidogrel for